The Predictive Value of Changes in the Absolute Counts of Peripheral Lymphocyte Subsets for Progression and Prognosis in Breast Cancer Patients

Table 2

Relationship between CD4⁺AC and clinicopathological parameters of breast cancer patients.

Characteristics	Low level	High level	χ^2	value
	<451 cells/μL	≥451 cells/μL
Age			3.072	0.08
<64	63	50
≥64	55	69
Family history			7.089	0.008
Yes	68	48
No	50	71
Previous medical history			4.393	0.036
Yes	105	94
No	13	25
Age of menarche			1.217	0.27
<12	56	65
≥12	62	54
Menopause			1.031	0.31
Yes	101	107
No	17	12
Tumor size			1.016	0.602
<2 cm	27	34
2-5 cm	66	61
>5 cm	25	24
Pathological category			10.215	0.001
ILC	6	22
IDC	112	97
Differentiation			0.777	0.378
High	25	31
Medium/low	93	88
Clinical stages			57.692	<0.001
I + II	16	73
III + IV	102	46
Lymph node metastasis			34.566	<0.001
Yes	100	58
No	18	61
Distant metastasis			48.305	<0.001
Yes	85	32
No	33	87
Vessel carcinoma embolus			28.04	<0.001
Yes	47	12
No	71	107
Treatments			22.069	<0.001
Surgery	42	41
Surgery + chemotherapy	55	27
Surgery + endocrinotherapy	21	51

Notes: ILC, invasive lobular carcinomas; IDC, invasive ductal carcinoma.